Short Interest in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Expands By 21.9%

Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Rating) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 14,330,000 shares, an increase of 21.9% from the May 15th total of 11,760,000 shares. Based on an average daily trading volume, of 2,610,000 shares, the days-to-cover ratio is presently 5.5 days.

Several large investors have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Sabra Health Care REIT by 6.1% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,827 shares of the real estate investment trust’s stock valued at $414,000 after purchasing an additional 1,602 shares during the period. Keeley Teton Advisors LLC raised its stake in shares of Sabra Health Care REIT by 13.3% during the 1st quarter. Keeley Teton Advisors LLC now owns 591,526 shares of the real estate investment trust’s stock valued at $8,808,000 after purchasing an additional 69,361 shares during the period. Weiss Multi Strategy Advisers LLC increased its stake in Sabra Health Care REIT by 230.8% in the 1st quarter. Weiss Multi Strategy Advisers LLC now owns 992,410 shares of the real estate investment trust’s stock worth $14,777,000 after acquiring an additional 692,438 shares during the last quarter. Advisors Asset Management Inc. increased its stake in Sabra Health Care REIT by 34.2% in the 1st quarter. Advisors Asset Management Inc. now owns 153,741 shares of the real estate investment trust’s stock worth $2,289,000 after acquiring an additional 39,170 shares during the last quarter. Finally, Jane Street Group LLC increased its stake in Sabra Health Care REIT by 604.1% in the 1st quarter. Jane Street Group LLC now owns 495,994 shares of the real estate investment trust’s stock worth $7,385,000 after acquiring an additional 425,549 shares during the last quarter. Institutional investors own 91.61% of the company’s stock.

Shares of SBRA opened at $13.55 on Friday. The stock’s fifty day moving average price is $13.11 and its two-hundred day moving average price is $13.44. The company has a debt-to-equity ratio of 0.70, a quick ratio of 3.60 and a current ratio of 3.60. Sabra Health Care REIT has a 1 year low of $11.44 and a 1 year high of $19.01.

Sabra Health Care REIT (NASDAQ:SBRAGet Rating) last released its quarterly earnings data on Wednesday, May 4th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sabra Health Care REIT had a negative return on equity of 3.15% and a negative net margin of 18.28%. During the same quarter last year, the business posted $0.39 EPS. As a group, analysts forecast that Sabra Health Care REIT will post 1.48 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 31st. Investors of record on Monday, May 16th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, May 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.86%. Sabra Health Care REIT’s payout ratio is -244.89%.

A number of analysts recently commented on the company. Capital One Financial started coverage on Sabra Health Care REIT in a research report on Friday, June 3rd. They issued an “equal weight” rating and a $15.50 price objective for the company. Credit Suisse Group boosted their target price on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “neutral” rating in a research note on Monday, April 4th. StockNews.com initiated coverage on Sabra Health Care REIT in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. KeyCorp began coverage on Sabra Health Care REIT in a research report on Friday, February 18th. They set a “sector weight” rating on the stock. Finally, Stifel Nicolaus decreased their target price on Sabra Health Care REIT from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Wednesday, February 23rd. Six investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $16.06.

Sabra Health Care REIT Company Profile (Get Rating)

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing – Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture.

Read More

Want More Great Investing Ideas?

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.